Zimmer Biomet Holdings ZBH Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$295.4M-0.9% | -$292.8M-3.5% | -$282.8M-8.1% | -$261.7M-12.1% | -$233.5M-7.1% | ||
| $8.41B+2.2% | $8.23B+2.8% | $8.01B+2.3% | $7.83B+1.8% | $7.7B+0.3% | ||
| $2.52B+1.1% | $2.49B+9.0% | $2.29B+0.9% | $2.27B+1.7% | $2.23B+1.7% | ||
| $5.89B+2.6% | $5.74B+0.3% | $5.72B+2.8% | $5.57B+1.8% | $5.47B-0.3% | ||
| 70%+0.3pp | 69.7%-1.7pp | 71.4%+0.4pp | 71.1%0.0pp | 71.1%-0.4pp | ||
| $451.3M-1.6% | $458.5M+2.3% | $448.3M+1.0% | $444M+0.9% | $440.1M+0.6% | ||
| $3.35B+2.8% | $3.26B+4.0% | $3.13B+3.4% | $3.03B+2.6% | $2.95B+0.8% | ||
| $676.9M+1.7% | $665.8M+3.1% | $645.7M+4.6% | $617.4M+2.8% | $600.8M+1.5% | ||
| $7.23B+1.4% | $7.13B+6.8% | $6.68B+1.6% | $6.57B+2.9% | $6.39B-0.1% | ||
| $1.18B+7.4% | $1.1B-17.6% | $1.33B+5.7% | $1.26B-3.9% | $1.31B+2.1% | ||
| 14%+0.7pp | 13.3%-3.3pp | 16.6%+0.5pp | 16.1%-0.9pp | 17%+0.3pp | ||
| $19.6M-23.1% | $25.5M+191% | -$28M-6.9% | -$26.2M+6.8% | -$28.1M+9.6% | ||
| $903.1M+8.7% | $830.8M-18.7% | $1.02B+5.0% | $972.9M-7.4% | $1.05B+1.3% | ||
| —— | —— | $214.6M+45.3% | $147.7M+8.9% | $135.6M+3.2% | ||
| $3.86+8.7% | $3.55-11.9% | $4.03-1.7% | $4.10-9.1% | $4.51+1.6% | ||
| $3.87+8.4% | $3.57-12.1% | $4.06-1.5% | $4.12-9.1% | $4.53+1.8% | ||
| 791.6M-0.5% | 795.5M-0.6% | 800.7M-0.5% | 804.9M-1.0% | 813M-0.8% | ||
| 789M-0.5% | 792.9M-0.6% | 798M-0.5% | 802.2M-1.0% | 810M-0.8% | ||
| $82M+6.5% | $77M+11.9% | $68.8M-36.1% | $107.6M+217% | $33.9M+43.0% | ||
| $676.9M+1.7% | $665.8M+3.1% | $645.7M+4.6% | $617.4M+2.8% | $600.8M+1.5% | ||
| -$295.4M-0.9% | -$292.8M-3.5% | -$282.8M-8.1% | -$261.7M-12.1% | -$233.5M-7.1% | ||
| $19.6M-23.1% | $25.5M+191% | -$28M-6.9% | -$26.2M+6.8% | -$28.1M+9.6% | ||
| $451.3M-1.6% | $458.5M+2.3% | $448.3M+1.0% | $444M+0.9% | $440.1M+0.6% | ||
| $151.5M-16.4% | $181.2M+89.1% | $95.8M-10.1% | $106.6M-18.4% | $130.6M-40.4% | ||
| $8.41B+2.2% | $8.23B+2.8% | $8.01B+2.3% | $7.83B+1.8% | $7.7B+0.3% | ||
| $1.18B+7.4% | $1.1B-17.6% | $1.33B+5.7% | $1.26B-3.9% | $1.31B+2.1% | ||
| $2.29B+4.4% | $2.19B-8.9% | $2.41B+4.5% | $2.3B-1.0% | $2.32B+1.8% | ||
| $2.29B+4.4% | $2.19B-8.9% | $2.41B+4.5% | $2.3B-1.0% | $2.32B+1.8% | ||
| 27.2%+0.6pp | 26.6%-3.4pp | 30%+0.7pp | 29.4%-0.8pp | 30.2%+0.5pp | ||
| $1.18B+7.4% | $1.1B-17.6% | $1.33B+5.7% | $1.26B-3.9% | $1.31B+2.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Zimmer Biomet Holdings's revenue?
- Zimmer Biomet Holdings (ZBH) generated $8.4B in revenue over the trailing twelve months, up 9.2% year over year.
- Is Zimmer Biomet Holdings profitable?
- Zimmer Biomet Holdings reported $761.1M in net income over the trailing twelve months, a 9.1% net margin.
- What are Zimmer Biomet Holdings's profit margins?
- Gross margin is 70.0% and operating margin is 14.0%, with a 9.1% net margin.
- What is Zimmer Biomet Holdings's earnings per share?
- Zimmer Biomet Holdings's diluted EPS over the trailing twelve months is $3.86.
- Where does Zimmer Biomet Holdings's income statement data come from?
- Every line is extracted from Zimmer Biomet Holdings's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
